← Back to Search

Digital Messaging Interventions for Physical Activity Promotion (TRY AIM Trial)

N/A

Recruiting

Led By David E Conroy, PhD

Research Sponsored by Penn State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from 12 months to 18 months

Awards & highlights

TRY AIM Trial Summary

This trial tests a messaging algorithm to see if it helps young adults become more active & slow weight gain. Participants will wear activity trackers & get messages with activities, quotes, or reminders. Researchers will compare the effects of the algorithm to random messages & no messages.

Who is the study for?

This trial is for young adults with a sedentary lifestyle who own a smartphone, are willing to wear an activity tracker almost all day for 12 months, and can read and understand English. It's not for those living outside the continental US, pregnant or planning pregnancy within a year, diagnosed with certain diseases, involved in other related studies, meeting current physical activity guidelines or unable to do moderate exercise.Check my eligibility

What is being tested?

The study tests if personalized text messages based on an algorithm (Precision AIM) increase physical activity more than random messages (Random AIM) or no motivational texts at all (No AIM). Participants will use an activity tracker and receive different types of messages over a year to see which method is most effective in promoting physical activity.See study design

What are the potential side effects?

Since this trial involves education and motivational messaging rather than medication or invasive procedures, there are minimal expected side effects. However, increased physical activity may lead to typical exercise-related discomforts such as muscle soreness.

TRY AIM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from 12 months to 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from 12 months to 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from 12 months to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average daily step counts (6 months)

Secondary outcome measures

Average daily step counts (12 months)

Average daily step counts (18 months)

Light intensity physical activity duration (12 months)

+11 more

TRY AIM Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Precision AIMExperimental Treatment3 Interventions

Education + activity monitor + up to 4 text messages/day, each drawn from one of 3 content libraries and timed based on a person- and context-specific algorithm that will be updated monthly based on incoming data (within a participant-defined availability window)

Group II: No AIMActive Control2 Interventions

Education + activity monitor

Group III: Random AIMActive Control3 Interventions

Education + activity monitor + up to 4 text messages/day, each drawn from one of 3 content libraries and timed at random (within a participant-defined availability window).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Activity tracker

2018

N/A

~230

Education

2017

N/A

~4770

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor

355 Previous Clinical Trials

125,397 Total Patients Enrolled

David E Conroy, PhDPrincipal InvestigatorThe Pennsylvania State University

4 Previous Clinical Trials

409 Total Patients Enrolled

Constantino M Lagoa, PhDPrincipal InvestigatorThe Pennsylvania State University

Media Library

Text messaging (precision dosing) Clinical Trial Eligibility Overview. Trial Name: NCT05794178 — N/A

Sedentary Lifestyle Research Study Groups: No AIM, Random AIM, Precision AIM

Sedentary Lifestyle Clinical Trial 2023: Text messaging (precision dosing) Highlights & Side Effects. Trial Name: NCT05794178 — N/A

Text messaging (precision dosing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05794178 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any criteria that would disqualify me from participating in this clinical trial?

"This clinical trial is recruiting approximately 360 candidates who lead a sedentary lifestyle and fall within the age range of 18-29."

Answered by AI

Are the criteria for this experiment inclusive of participants over the age of 55?

"This clinical trial is solely for patients aged 18-29, however there are 29 trials available to participants under the age of consent and 87 studies open to those over 65."

Answered by AI

How many patients are presently being enrolled in this investigation?

"Affirmative. The information found on clinicaltrials.gov verifies that this medical experiment is presently enrolling participants and has been since March 31st 2023, with the most recent revision made April 21st 2023. 360 individuals are needed to be recruited from 1 location for completion of this study."

Answered by AI

Is enrollment for this experimental protocol still available?

"That is correct. According to the information posted on clinicaltrials.gov, this trial commenced recruitment on March 31st 2023 and was last edited April 21st 2023; it calls for 360 participants from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial

David E Conroy 2023. "Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05794178.

All > Weight Gain